Downstaging with Atezolizumab-Bevacizumab: A Case Series.

Anand V KulkarniKumaraswamy PBalachandran MenonAnuradha SekaranAnuhya RambhatlSowmya IyengarManasa AllaShantan VenishettySumana Kolar RamachandraPremkumar G VMithun SharmaP N RaoDuvvur Nageshwar ReddyAmit G Singal

Published in: Journal of liver cancer (2024)

Surgical therapy, including LT, is possible after atezo-bev therapy in wellselected patients after downstaging.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
mesenchymal stem cells
bone marrow
metastatic colorectal cancer